GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...
Zydus gets WHO nod for its typhoid vaccineZydus Lifesciences Ltd has received in-principle approval from the WHO for its Typhoid Vi conjugate vaccine, ZyVac TCV. Eligible for UN pro...
CoronaVac vaccine: its results are patchy, but the world can't ignore its usefulnessThe latter, developed by the Sinovac Biotech company, is the latest COVID-19 vaccine to be authorised for emergency use by the World Health...
EU regulator does not expect approval for CureVac vaccine before AugustThe source said German health minister Jens Spahn had provided the update on the EMA's view on the timing of the review on Monday in a call...
Kazakhstan joins select list of countries to produce Covid vaccineThe first 50,000 doses of QazVac vaccine will be distributed among pharmacy hubs and delivered to all regions of the country.
Novartis agrees to make ingredients Roche's Actemra for COVID-19 patientsThe arrangement is the third transaction signed by Novartis following agreements with BioNTech and CureVac to make therapies for other firm...
Pakistan approves emergency use of third Chinese COVID-19 vaccine despite low efficacy rateThe Drug Regulatory Authority of Pakistan (DRAP) on Thursday granted Emergency Use Authorisation (EUA) to CoronaVac, developed by Chinese c...
Sinovac vaccine may not trigger sufficient antibody response to Brazil variant, says studyThe emergence of variants of the new coronavirus has raised concern that vaccines and treatments that were developed based on previous stra...
GSK, CureVac partnership eyes COVID-19 vaccine against multiple variantsGSK, which holds a stake in CureVac, will also support the production of up to 100 million doses of CureVac's first generation COVID-19 vac...
Bayer aims to help CureVac with COVID-19 vaccine output, says CEOThough inoculation campaigns have started around the world using various COVID-19 vaccines, many countries say their ability to get shots i...
COVID-19 vaccine contender CureVac links up with BayerCureVac, based in the German city of Tuebingen, said last month that it expects first results by the end of March from its phase 3 clinical...
EU could pay over $10 billion for Pfizer, CureVac vaccinesThe European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfi...
Halted Brazil trials of Chinese-made coronavirus vaccine cause surpriseThe potential vaccine is being developed by Chinese biopharmaceutical firm Sinovac and in Brazil would be mostly produced by Sao Paulo's st...
GSK collaborates with Germany's CureVac, set to take 10% stake for $163 millionBritain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...
Germany tries to stop US from luring away firm seeking coronavirus vaccineOn its website, CureVac said CEO Daniel Menichella early this month met Trump, Vice President Mike Pence, members of the White House Corona...
New UK visa application centre formally opened in HyderabadBritish Deputy High Commissioner for Hyderabad Andrew McAllister formally opened UK and Ireland's new Visa Application Centre on Banjara Hi...
Swiss visa centres in ten more citiesApplying for visa for Switzerland will become easier as Swiss visa application centres (VAC) will soon be opened in 10 more cities.